Co-morbidity burden in Parkinson’s disease : Comparison with controls and its influence on prognosis

Financial support This study was funded by Parkinson’s UK, the Scottish Chief Scientist Office, NHS Grampian endowments, the BMA Doris Hillier award, RS Macdonald Trust, the BUPA Foundation, and SPRING. The funders had no involvement in the study. Acknowledgements We acknowledge funding for the PINE study from Parkinson’s UK (G-0502, G-0914, G-1302), the Scottish Chief Scientist Office(CAF/12/05), the BMA Doris Hillier award, RS Macdonald Trust, the BUPA Foundation, NHS Grampian endowments and SPRING. We thank the patients and controls for their participation and the research staff who collected data and supported the study database.Peer reviewedPostprintPostprintPublisher PD

Accuracy of death certificates for recording parkinsonian syndromes and associated dementia

Acknowledgements We thank the members of the PINE study team who have collected and entered the data and managed the database: Kate Taylor, Robert Caslake, Angus Macleod, David McGhee, Diane Swallow, Joanne Gordon, Clare Harris, Ann Hayman, Hazel Forbes, Valerie Angus, Alasdair Finlayson, David Dawson, Katie Wilde, David Ritchie, Artur Wozniak, Aileen Sylvester, Susan Mitchell, Pam Rebecca, Ann Christie, and Diane McCosh. The PINE study was funded by Parkinson’s UK, the Scottish Chief Scientist Office, NHSGrampian endowments, the BMA Doris Hillier award, RS Macdonald Trust, the BUPA Foundation and SPRING.Peer reviewedPostprin

Anticoagulants for acute ischaemic stroke

Peer reviewedPublisher PD

Using 'dead or dependent' as an outcome measure in clinical trials in Parkinson's disease

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.Peer reviewedPublisher PD

The epidemiology of infectious mononucleosis in Northern Scotland : a decreasing incidence and winter peak

Peer reviewedPublisher PD

Season of birth and risk of developing idiopathic Parkinson's disease

Peer reviewedPreprintPreprin

The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson's disease (PD)

Funding Dr Swallow received a clinical research fellowship jointly funded by the Chief Scientist Office (CSO) of the Scottish Government and PSP Association. The PINE study is funded by Parkinson’s UK, the Scottish Chief Scientist Office, the BMA Doris Hillier award, RS Macdonald Trust, the BUPA Foundation, NHS Grampian endowments and SPRING.Peer reviewedPublisher PD

Season of infectious mononucleosis as a risk factor for multiple sclerosis : a UK primary care case-control study

This study is based in part on data from the Full Feature General Practice Research Database obtained under licence from the UK Medicines and Healthcare Products Regulatory Agency. However, the interpretation and conclusions contained in this study are those of the authors alone. Access to the GPRD database was funded through the Medical Research Council’s licence agreement with MHRA. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. We acknowledge the data management support of the Grampian Data Safe Haven (DaSH) and the associated financial support of NHS Research Scotland through NHS Grampian investment in the Grampian DaSH.Peer reviewedPostprintPostprintPostprin

Early weight loss in parkinsonism predicts poor outcomes : evidence from an incident cohort study

This study was funded by Parkinson’s UK, the Scottish Chief Scientist Office, NHS Grampian endowments, the BMA Doris Hillier award, RS Macdonald Trust, the BUPA Foundation, and the Special Parkinson’s Research Interest Group (SPRING). The Article Processing Charge was funded by Parkinson's UK.Peer reviewedPublisher PD